Cramer’s lightning round: Stay away from CoreCivic

Cramer’s lightning round: Stay away from CoreCivic


Loading chart…

CoreCivic Inc: “Let’s just stay away.”

Loading chart…

Inmode Ltd: “If you want med tech, you just want Edwards Lifesciences.”

Loading chart…

Western Midstream Partners LP: “This one’s got a great yield, really good story.”

Loading chart…

SGHC Limited: “They are doing well, and I don’t say that idly.”

Loading chart…

Enterprise Products Partners LP: “They are the best in what they do.”

Loading chart…

United States Steel Corp: “If you’re going to own a steel company, which I don’t honestly recommend right now, you’re going to own Nucor.”

Loading chart…

Teva Pharmaceutical Industries Ltd: “I would prefer to see you in something like a [Johnson & Johnson].”

Loading chart…

AST SpaceMobile Inc: “I do not know that company, but we will do homework on it.”

VIDEO5:3105:31

Cramer’s lightning round: Stay away from CoreCivic

Mad Money with Jim Cramer

Sign up now for the CNBC Investing Club to follow Jim Cramer’s every move in the market.

Disclaimer

Questions for Cramer?
Call Cramer: 1-800-743-CNBC

Want to take a deep dive into Cramer’s world? Hit him up!
Mad Money TwitterJim Cramer Twitter – Facebook – Instagram

Questions, comments, suggestions for the “Mad Money” website? [email protected]





Source

Inside the booming business of wellness third spaces and membership clubs
Business

Inside the booming business of wellness third spaces and membership clubs

A few years ago, Grace Guo began to crave places in New York City where hanging out with friends didn’t have to involve alcohol. Newly sober and surrounded by friends who also chose not to drink, Guo said she wanted alternatives to the typical social scene. After some research, she landed on Bathhouse and Othership: […]

Read More
FDA vaccine head will step down in April after string of controversial decisions
Business

FDA vaccine head will step down in April after string of controversial decisions

The logo for the Food and Drug Administration is seen ahead of a news conference at the Health and Human Services Headquarters in Washington, DC on April 22, 2025. Nathan Posner | Anadolu | Getty Images A key U.S. Food and Drug Administration official who oversees vaccines and biotech treatments will step down from the […]

Read More
FDA reversals leave investors worrying about the fates of other experimental drugs
Business

FDA reversals leave investors worrying about the fates of other experimental drugs

Investors are concerned about the fates of multiple experimental drugs for hard-to-treat diseases following a string of recent rejections from the U.S. Food and Drug Administration.  The FDA in the past year has denied or discouraged the applications of at least eight drugs, according to RTW Investments, including a gene therapy for Huntington’s disease from […]

Read More